DW-14006

N/A

Report date: 2022/01/10 11:26:45
NME

Base Information

Drug NameDW-14006
Drug Alias NameDW-14006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases inhibitors
TargetsAMP-activated protein kinases
Therapy Area/IndicationsDiabetic peripheral neuropathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing University Of Chinese Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNanjing University Of Chinese Medicine
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A